JAM
IRWD icon

Jupiter Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jupiter Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,223,275
Closed -$1.8M – 478
2025
Q1 		$1.8M Hold
1,223,275
– – 0.02% 341
2024
Q4 		$5.42M Sell
1,223,275
-225,160
-16% -$914K 0.05% 273
2024
Q3 		$5.97M Hold
1,448,435
– – 0.05% 268
2024
Q2 		$9.44M Sell
1,448,435
-31,529
-2% -$223K 0.09% 216
2024
Q1 		$12.9M Sell
1,479,964
-790,078
-35% -$9.59M 0.12% 197
2023
Q4 		$26M Buy
2,270,042
+59,057
+3% +$584K 0.26% 124
2023
Q3 		$21.3M Buy
2,210,985
+1,879,401
+567% +$18.4M 0.24% 129
2023
Q2 		$3.52M Sell
331,584
-99,683
-23% -$1.07M 0.04% 310
2023
Q1 		$4.54M Buy
431,267
+187,690
+77% +$2.1M 0.06% 222
2022
Q4 		$3.02M Sell
243,577
-46,425
-16% -$527K 0.04% 256
2022
Q3 		$3M Sell
290,002
-1,819,528
-86% -$20.6M 0.05% 302
2022
Q2 		$24.3M Buy
2,109,530
+232,803
+12% +$2.74M 0.34% 87
2022
Q1 		$23.6M Buy
1,876,727
+155,771
+9% +$1.79M 0.28% 111
2021
Q4 		$20.1M Buy
1,720,956
+183,694
+12% +$2.25M 0.22% 134
2021
Q3 		$20.1M Sell
1,537,262
-10,190
-0.7% -$132K 0.23% 125
2021
Q2 		$19.9M Buy
1,547,452
+1,111,923
+255% +$12.7M 0.21% 136
2021
Q1 		$4.87M Buy
435,529
+13,181
+3% +$139K 0.05% 324
2020
Q4 		$4.81M Buy
422,348
+376,857
+828% +$4.12M 0.05% 316
2020
Q3 		$409K Buy
+45,491
New +$452K ﹤0.01% 520

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jupiter Asset Management's IRWD Position: Q2 2025 in Review

Jupiter Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 1,223,275 shares — an estimated $1.8M sold.

Jupiter Asset Management first reported a position in IRWD in Q3 2020 and held it in 19 quarters. The position peaked at $26M in Q4 2023. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • Jupiter Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Jupiter Asset Management sold 1,223,275 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $1.8M.
  • Jupiter Asset Management first reported a position in Ironwood Pharmaceuticals in Q3 2020 and held it in 19 quarters.
  • Jupiter Asset Management's Ironwood Pharmaceuticals position peaked at $26M in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Jupiter Asset Management's 13F filing for Q2 2025, filed 8 Aug 2025.